461 related articles for article (PubMed ID: 30834473)
1. Balancing medication use in nursing home residents with life-limiting disease.
Paque K; Elseviers M; Vander Stichele R; Pardon K; Vinkeroye C; Deliens L; Christiaens T; Dilles T
Eur J Clin Pharmacol; 2019 Jul; 75(7):969-977. PubMed ID: 30834473
[TBL] [Abstract][Full Text] [Related]
2. Use and Deprescribing of Potentially Inappropriate Medications in Frail Nursing Home Residents.
Fournier A; Anrys P; Beuscart JB; Dalleur O; Henrard S; Foulon V; Spinewine A
Drugs Aging; 2020 Dec; 37(12):917-924. PubMed ID: 33047252
[TBL] [Abstract][Full Text] [Related]
3. Discontinuation of medications at the end of life: A population study in Belgium, based on linked administrative databases.
Paque K; De Schreye R; Elseviers M; Vander Stichele R; Pardon K; Dilles T; Christiaens T; Deliens L; Cohen J
Br J Clin Pharmacol; 2019 Apr; 85(4):827-837. PubMed ID: 30667540
[TBL] [Abstract][Full Text] [Related]
4. Effects of an interprofessional Quality Circle-Deprescribing Module (QC-DeMo) in Swiss nursing homes: a randomised controlled trial.
Cateau D; Ballabeni P; Niquille A
BMC Geriatr; 2021 May; 21(1):289. PubMed ID: 33933030
[TBL] [Abstract][Full Text] [Related]
5. Effects of an interprofessional deprescribing intervention in Swiss nursing homes: the Individual Deprescribing Intervention (IDeI) randomised controlled trial.
Cateau D; Ballabeni P; Niquille A
BMC Geriatr; 2021 Nov; 21(1):655. PubMed ID: 34798826
[TBL] [Abstract][Full Text] [Related]
6. Potentially inappropriate medication use in nursing homes: an observational study using the NORGEP-NH criteria.
Nyborg G; Brekke M; Straand J; Gjelstad S; Romøren M
BMC Geriatr; 2017 Sep; 17(1):220. PubMed ID: 28927372
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
Komagamine J; Sugawara K; Hagane K
BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
[TBL] [Abstract][Full Text] [Related]
8. Deprescribing in nursing homes: Protocol for nested, randomised controlled hybrid trials of deprescribing interventions.
Cateau D; Ballabeni P; Mena S; Bugnon O; Niquille A
Res Social Adm Pharm; 2021 Apr; 17(4):786-794. PubMed ID: 32622774
[TBL] [Abstract][Full Text] [Related]
9. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
[TBL] [Abstract][Full Text] [Related]
10. Frailty and Potentially Inappropriate Medication Use at Nursing Home Transition.
Maclagan LC; Maxwell CJ; Gandhi S; Guan J; Bell CM; Hogan DB; Daneman N; Gill SS; Morris AM; Jeffs L; Campitelli MA; Seitz DP; Bronskill SE
J Am Geriatr Soc; 2017 Oct; 65(10):2205-2212. PubMed ID: 28752589
[TBL] [Abstract][Full Text] [Related]
11. The DE-PHARM Project: A Pharmacist-Driven Deprescribing Initiative in a Nursing Facility.
Pruskowski J; Handler SM
Consult Pharm; 2017 Aug; 32(8):468-478. PubMed ID: 29029668
[TBL] [Abstract][Full Text] [Related]
12. Deprescribing Opportunities for Frail Residents of Nursing Homes: A Multicenter Study in Australia, China, Japan, and Spain.
Liau SJ; Zhao M; Hamada S; Gutiérrez-Valencia M; Jadczak AD; Li L; Martínez-Velilla N; Sakata N; Fu P; Visvanathan R; Lalic S; Roncal-Belzunce V; Bell JS
J Am Med Dir Assoc; 2024 May; 25(5):876-883. PubMed ID: 38423513
[TBL] [Abstract][Full Text] [Related]
13. Benzodiazepine Use and Deprescribing in Belgian Nursing Homes: Results from the COME-ON Study.
Evrard P; Henrard S; Foulon V; Spinewine A
J Am Geriatr Soc; 2020 Dec; 68(12):2768-2777. PubMed ID: 32786002
[TBL] [Abstract][Full Text] [Related]
14. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
Balsom C; Pittman N; King R; Kelly D
Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991
[TBL] [Abstract][Full Text] [Related]
15. Are residents of aged care facilities willing to have their medications deprescribed?
Kalogianis MJ; Wimmer BC; Turner JP; Tan EC; Emery T; Robson L; Reeve E; Hilmer SN; Bell JS
Res Social Adm Pharm; 2016; 12(5):784-8. PubMed ID: 26850702
[TBL] [Abstract][Full Text] [Related]
16. Drug consumption and futile medication prescribing in the last year of life: an observational study.
Curtin D; O'Mahony D; Gallagher P
Age Ageing; 2018 Sep; 47(5):749-753. PubMed ID: 29688246
[TBL] [Abstract][Full Text] [Related]
17. The MedSafer Study: A Controlled Trial of an Electronic Decision Support Tool for Deprescribing in Acute Care.
McDonald EG; Wu PE; Rashidi B; Forster AJ; Huang A; Pilote L; Papillon-Ferland L; Bonnici A; Tamblyn R; Whitty R; Porter S; Battu K; Downar J; Lee TC
J Am Geriatr Soc; 2019 Sep; 67(9):1843-1850. PubMed ID: 31250427
[TBL] [Abstract][Full Text] [Related]
18. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
[TBL] [Abstract][Full Text] [Related]
19. Potentially Inappropriate Medications in Older Adults: Deprescribing with a Clinical Pharmacist.
Ammerman CA; Simpkins BA; Warman N; Downs TN
J Am Geriatr Soc; 2019 Jan; 67(1):115-118. PubMed ID: 30300947
[TBL] [Abstract][Full Text] [Related]
20. Patterns of oral bisphosphonate deprescribing in older nursing home residents with dementia.
Niznik JD; Aspinall SL; Hanson LC; Gilliam MA; Li X; Kelley CJ; Thorpe CT
Osteoporos Int; 2022 Feb; 33(2):379-390. PubMed ID: 34480586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
